SPRC - SciSparc Ltd.
0.36
-0.040 -11.111%
Share volume: 2,872,387
Last Updated: 03-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.40
-0.04
-0.10%
Fundamental analysis
8%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
20%
Performance
5 Days
12.64%
1 Month
-2.70%
3 Months
-2.70%
6 Months
-2.70%
1 Year
-2.70%
2 Year
-2.70%
Key data
Stock price
$0.36
DAY RANGE
$0.32 - $0.39
52 WEEK RANGE
$0.30 - $0.52
52 WEEK CHANGE
-$2.70
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Oz Adler
Region: US
Website: scisparc.com
Employees: 4
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Region: US
Website: scisparc.com
Employees: 4
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
SciSparc Ltd. develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation. SCi-160 for the. treatment of pain; SCII-210 for the. treatment of autism spectrum disorder and epilepsy. The company was formerly known as Therapix Biosciences.
Recent news